We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+50.01%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$706M
AUM Growth
+$36.9M
Cap. Flow
-$61.8M
Cap. Flow %
-8.75%
Top 10 Hldgs %
9.19%
Holding
369
New
130
Increased
12
Reduced
108
Closed
118

Top Sells

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$8.34M
2
ZETA icon
Zeta Global
ZETA
+$6.87M
3
ENSG icon
The Ensign Group
ENSG
+$6.17M
4
LNTH icon
Lantheus
LNTH
+$5.84M
5
UFPT icon
UFP Technologies
UFPT
+$5.58M

Sector Composition

Rank Sector Weight
1 Technology 28.54%
2 Industrials 16.44%
3 Healthcare 14.11%
4 Financials 11.8%
5 Consumer Discretionary 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLPT icon
226
ClearPoint Neuro
CLPT
$433M
$739K 0.1%
48,034
-30,958
-39% -$401K
MYO icon
227
Myomo
MYO
$56.2M
$724K 0.1%
112,410
-41,785
-27% -$203K
LSF icon
228
Laird Superfood
LSF
$47.8M
$721K 0.1%
91,525
-80,233
-47% -$613K
ATOM icon
229
Atomera
ATOM
$212M
$710K 0.1%
+61,177
New +$352K
PPIH
230
Perma-Pipe International
PPIH
$215M
$708K 0.1%
+47,334
New +$687K
EQBK icon
231
Equity Bancshares
EQBK
$1.05B
$707K 0.1%
16,676
-4,351
-21% -$193K
SPIR icon
232
Spire Global
SPIR
$555M
$700K 0.1%
+49,746
New +$608K
PPTA
233
Perpetua Resources
PPTA
$3.09B
$688K 0.1%
64,437
-3,542
-5% -$36.3K
GHM icon
234
Graham Corp
GHM
$1.31B
$685K 0.1%
15,397
-8,454
-35% -$316K
SSBK
235
DELISTED
Southern States Bancshares
SSBK
$671K 0.1%
+20,143
New +$679K
ORRF icon
236
Orrstown Financial Services
ORRF
$838M
$670K 0.09%
18,299
-9,378
-34% -$356K
FUNC icon
237
First United
FUNC
$289M
$658K 0.09%
19,508
-1,051
-5% -$34.9K
NECB icon
238
Northeast Community Bancorp
NECB
$367M
$646K 0.09%
26,430
-15,867
-38% -$436K
NGVC icon
239
Vitamin Cottage Natural Grocers
NGVC
$654M
$644K 0.09%
16,216
-29,475
-65% -$1.02M
SRTS icon
240
Sensus Healthcare
SRTS
$50.5M
$637K 0.09%
92,103
-4,964
-5% -$36.4K
MLR icon
241
Miller Industries
MLR
$619M
$624K 0.09%
9,542
-3,200
-25% -$218K
TE
242
T1 Energy
TE
$1.63B
$614K 0.09%
+238,119
New +$400K
AXGN icon
243
Axogen
AXGN
$2.5B
$602K 0.09%
36,547
-33,529
-48% -$475K
SMBK icon
244
SmartFinancial
SMBK
$888M
$579K 0.08%
+18,694
New +$618K
BSVN icon
245
Bank7 Corp
BSVN
$481M
$570K 0.08%
12,217
-658
-5% -$29K
CAPR icon
246
Capricor Therapeutics
CAPR
$237M
$528K 0.07%
38,276
-31,649
-45% -$555K
SPFI icon
247
South Plains Financial
SPFI
$841M
$480K 0.07%
13,812
-11,628
-46% -$422K
AMSC icon
248
American Superconductor
AMSC
$1.59B
$467K 0.07%
18,967
-114,218
-86% -$3.15M
ESP icon
249
Espey Mfg & Electronics Corp
ESP
$187M
$462K 0.07%
+15,313
New +$461K
ELDN icon
250
Eledon Pharmaceuticals
ELDN
$285M
$451K 0.06%
+109,555
New +$432K

Similar funds

EAM Investors's Q4 2024 Portfolio in Review

As of Q4 2024, EAM Investors held 369 positions worth $706M, up 5.5% from $669M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

EAM Investors withdrew a net $61.8M in Q4 2024, closing 118 positions and reducing 108 holdings. Its most notable exit was Vaxcyte, an estimated $8.34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, EAM Investors opened a new position in EXL Service worth $6.18M.

  • EAM Investors's largest Q4 2024 buy was EXL Service: 139,191 shares worth $6.18M.
  • EAM Investors added most to Turning Point Brands in Q4 2024, an estimated $3.01M increase.
  • EAM Investors's biggest Q4 2024 reduction was Sprouts Farmers Market, cutting an estimated $5.38M.
  • EAM Investors fully exited Vaxcyte in Q4 2024, selling an estimated $8.34M.
  • EAM Investors's ten largest holdings make up 9.2% of its $706M portfolio in Q4 2024.
  • EAM Investors opened 130 new positions and closed 118 in Q4 2024.
  • EAM Investors's portfolio value rose 5.5% quarter-over-quarter to $706M.

Based on EAM Investors's 13F filing for Q4 2024, filed 13 Feb 2025.